Facial swelling in giant cell (temporal) arteritis

Eye

Volumn 10, Issue 6, 1996, Pages 747-749

  Ghanchi, Faruque D ^a,b   Weir, Clifford ^a   Dudgeon, John ^a  

^a Tennent Institute of Ophthalmology ^*

^b Tennent Institute of Ophthalmology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; STEROID;

AGED; ARTICLE; CASE REPORT; FACE EDEMA; FEMALE; GIANT CELL ARTERITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; SYSTEMIC VASCULITIS; TEMPORAL ARTERITIS; VISUAL IMPAIRMENT;

EID: 0030448303     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.174     Document Type: Article

References (14)

1. Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis: a pathological study to show the pattern of arterial involvement. Arch Neurol 1972;27:378-91.
2. Hayreh SS. Ophthalmic features of giant cell arteritis. Baillieres Clin Rheumatol 1991;5:431-59.
3. Cohen MD, Ginsburg WW, Allen GL. Facial swelling and giant cell arteritis. J Rheumatol 1982;9:325-7.
4. Manganelli P, Malvezzi L, Saginario A. Trismus and facial swelling in a case of temporal arteritis. Clin Exp Rheumatol 1992;10:102-3.
5. Friedman G, Friedman B. The sensation of facial swelling in temporal arteritis: a predictor for the development of visual disturbance. Postgrad Med J 1986;62:1019-20.
6. Fainaru M, Friedman G, Friedman B. Temporal arteritis in Israel: a review of 47 patients. J Rheumatol 1979;6:330-5.
7. Achkar AA, Lie JT, Gabriel SE, Hunder GG. Giant cell arteritis involving the facial artery. J Rheumatol 1995;22:360-2.
8. Model DG. Reversal of blindness in temporal arteritis with methylprednisolone. Lancet 1978;2:340.
9. Rosenfeld SI, Kosmorsky GS, Klingele TG, Burde RM, Cohn EM. Treatment of temporal arteritis with ocular involvement. Am J Med 1986;80:143-5.
10. Diamond JP. Treatable blindness in temporal arteritis. Br J Ophthalmol 1991;75:432.
11. Matzkin DC, Slamovits TL, Sachs R, Burde RM. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis. Ophthalmology 1992;99:68-71.
12. Postel EA, Pollock SC. Recovery of vision in a 47-year-old man with fulminant giant cell arteritis. J Clin Neuroophthalmol 1993;13:262-70.
13. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis: clinical characteristics and prognosis for vision. Ophthalmology 1994; 101:1779-85.
14. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischaemia: the ischaemic penumbra. Stroke 1981; 12:723-5.